| Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 1882 | 2020 |
| Evolution of antibody immunity to SARS-CoV-2 C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ... Nature 591 (7851), 639-644, 2021 | 1747 | 2021 |
| FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair P Mathiyalagan, M Adamiak, J Mayourian, Y Sassi, Y Liang, N Agarwal, ... Circulation 139 (4), 518-532, 2019 | 477 | 2019 |
| Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms AE Livanos, D Jha, F Cossarini, AS Gonzalez-Reiche, M Tokuyama, ... Gastroenterology 160 (7), 2435-2450. e34, 2021 | 153 | 2021 |
| Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2–related Disease M Suárez-Fariñas, M Tokuyama, G Wei, R Huang, A Livanos, D Jha, ... Gastroenterology 160 (1), 287-301. e20, 2021 | 134 | 2021 |
| Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity M Uzzan, JC Martin, L Mesin, AE Livanos, T Castro-Dopico, R Huang, ... Nature medicine 28 (4), 766-779, 2022 | 107 | 2022 |
| Advancing scientific knowledge in times of pandemics N Vabret, R Samstein, N Fernandez, M Merad, ... Nature reviews Immunology 20 (6), 338-338, 2020 | 64 | 2020 |
| Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19 GJ Britton, A Chen-Liaw, F Cossarini, AE Livanos, MP Spindler, T Plitt, ... Scientific Reports 11 (1), 13308, 2021 | 63 | 2021 |
| Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent V Upadhyay, A Singh, D Jha, A Singh, AK Panda Microbial cell factories 15 (1), 1-13, 2016 | 51 | 2016 |
| Gastrointestinal involvement attenuates COVID-19 severity and mortality AE Livanos, D Jha, F Cossarini, AS Gonzalez-Reiche, M Tokuyama, ... MedRxiv, 2020.09. 07.20187666, 2020 | 41 | 2020 |
| SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19 GJ Britton, A Chen-Liaw, F Cossarini, AE Livanos, MP Spindler, T Plitt, ... MedRxiv, 2020.09. 03.20183947, 2020 | 29 | 2020 |
| Extracellular Vesicle–Encapsulated Adeno-Associated Viruses for Therapeutic Gene Delivery to the Heart X Li, S La Salvia, Y Liang, M Adamiak, E Kohlbrenner, D Jeong, ... Circulation 148 (5), 405-425, 2023 | 22 | 2023 |
| Self-assembling tryptophan-based designer peptides as intracellular delivery vehicles I Bhardwaj, D Jha, P Admane, AK Panda, V Haridas Bioorganic & medicinal chemistry letters 26 (2), 672-676, 2016 | 17 | 2016 |
| Antimicrobial therapeutics delivery systems based on biodegradable polylactide/polylactide-co-glycolide particles R Kumar, D Jha, AK Panda Environmental Chemistry Letters 17, 1237-1249, 2019 | 14 | 2019 |
| Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis P Canales-Herrerias, M Uzzan, A Seki, RS Czepielewski, B Verstockt, ... Science Immunology 9 (94), eadg7549, 2024 | 13 | 2024 |
| 1161: PERSISTENT IMMUNE CELL ABNORMALITIES IN THE INTESTINAL MUCOSA OF PATIENTS AFTER RECOVERY FROM COVID-19 INFECTION H Meringer, M Tokuyama, M Tankelevich, G Martinez-Delgado, D Jha, ... Gastroenterology 162 (7), S-277, 2022 | 3 | 2022 |
| Poly-Lactide/Poly-Lactide-co-Glycolide-Based Delivery System for Bioactive Compounds against Microbes R Kumar, D Jha, AK Panda Pharmaceuticals from Microbes: The Bioengineering Perspective, 75-98, 2019 | 3 | 2019 |
| OP39 Vedolizumab response in ulcerative colitis associates with reduced IgG+ plasma cells and FcγR signaling P Canales-Herrerias, M Uzzan, Z Al-taie, A Seki, B Verstockt, A Livanos, ... Journal of Crohn's and Colitis 18 (Supplement_1), i69-i70, 2024 | 2 | 2024 |
| SARS-CoV-2 persists in intestinal enterocytes up to 7 months after symptom resolution M Tokuyama, MS Ladinsky, D Jha, F Cossarini, AE Livanos, J Reidy, ... Topics in Antiviral Medicine, 30-30, 2021 | 2 | 2021 |
| DOP19 Myeloid and lymphoid cell abnormalities persist in the intestinal mucosa of patients who recover from COVID-19 infection H Meringer, M Tokuyama, M Tankelevich, G Martinez-Delgado, D Jha, ... Journal of Crohn's and Colitis 16 (Supplement_1), i068-i069, 2022 | 1 | 2022 |
